Morphine Sulfate Capsule, Extended Release
Product Images NDC 0228-3091

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 24 technical images submitted to the FDA as part of the official labeling for Morphine Sulfate (NDC 0228-3091). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 1

FDA Label Image

Image 10

FDA Label Image

Image 11

FDA Label Image

Image 12

FDA Label Image

Image 13

FDA Label Image

Image 14

FDA Label Image

Image 15

FDA Label Image

Image 16

FDA Label Image

Image 17

FDA Label Image

Image 18

FDA Label Image

Image 19

Image 19
This is a medication called Morphine Sulfate Extended-Release Capsules, used in pain management. It comes in a bottle containing 100 capsules of 30mg each, with a prescription requirement. The usual dosage is once daily, and it should not be crushed, chewed, or dissolved. It should be kept out of reach of children and protected from light and moisture. It needs to be stored in a tight, light-resistant container at a temperature of 25°C (77°F); excursions are permitted to 15° to 30°C (59° to 86°F). The accompanying Medication Guide should be provided to each patient by the pharmacist. The product is manufactured by Teva Pharmaceuticals, located in Parsippany, NJ 07054. The LOT/EXP number is 52-0144, and it has a Serialization Coding Area. Information about the product can be found at www.tevausa.com/medguides.*
FDA Label Image

Image 2

FDA Label Image

Image 20

Image 20
This is a description of a medication product containing Morphine Sulfate in Extended-Release Capsules, USP, with a strength of 45mg. The usual dosage is once a day and it is important not to crush, chew, or dissolve the capsule. The medication guide should be dispensed to each patient by the pharmacist. The medication should be stored at a temperature between 15°C to 30°C and should be kept away from light and moisture. The medication should be dispensed in a tight, light-resistant container as defined in the USP. The product is manufactured by Teva Pharmaceuticals and it is only available with a prescription. Lot/Exp numbers are printed on the package for traceability purpose.*
FDA Label Image

Image 21

Image 21
This is a medication called Morphine Sulfate Extended-Release Capsules, USP. It comes in a package of 100 capsules and each capsule contains 60 mg of Morphine Sulfate, USP. The usual dosage is once per day and it should not be crushed, chewed, or dissolved. The medication guide should be given to each patient by the pharmacist. The medicine should be protected from light and moisture and kept away from children. It should be stored in a container that is light-resistant. It's manufactured by Teva Pharmaceuticals in Parsippany, NJ. There is serialization coding on the medication. Print Medication Guides can be found at the website of the manufacturer.*
FDA Label Image

Image 22

Image 22
This is a prescription medication named Morphine Sulfate Extended-Release Capsules, USP with 75 mg dosage, manufactured by Teva Pharmaceuticals. The medication is dispensed in a container with 100 capsules, and the regular dosage is once daily. The patients should be given the accompanying medication guide, and the capsules should not be crushed, chewed or dissolved. The medication must be kept protected from light and moisture at a temperature ranging from 15°C to 30°C. The lot/exp number provided is U228=3117=]11. Medication guides are available at www.tevausa.com/medguides.*
FDA Label Image

Image 23

Image 23
This is a medication guide for Morphine Sulfate Extended-Release capsules that come in a bottle of 100 capsules, containing 90 mg of Morphine Sulfate in each extended-release capsule. These capsules are only for use in opioid-tolerant patients, and the recommended dose is once a day, following the package literature. The capsules should not be crushed, chewed, or dissolved, should be protected from moisture and light, and need to be kept out of the reach of children. They should be stored in a tight, light-resistant container, between temperatures of 15°C to 30°C (59°F to 86°F). The accompanying medication guide should be dispensed to each patient by the pharmacist. The medication guide is available at www.tevausa.com/medguides. The lot/exp and other information about the product can be found on the Serialization Coding Area.*
FDA Label Image

Image 24

Image 24
This is a medication called Morphine Sulfate, which is available in the form of 100 extended-release capsules. The capsules contain USP Morphine Sulfate of 120mg each and are intended for use by opioid-tolerant patients only. The recommended dosage is once daily, and the capsules should not be crushed, chewed, or dissolved. The medication guide needs to be dispensed by the pharmacist, and the medication needs to be stored at a temperature between 15° to 30°C (59° to 86°F), protected from light and moisture. It's a prescription drug dispensed in a tight, light-resistant container as defined in the USP. The medication manufactured by Teva Pharmaceuticals and it's not available for all individuals, and the LOT/EXP must be below 0228-3093-11 for usage.*
FDA Label Image

Image 3

FDA Label Image

Image 4

FDA Label Image

Image 5

FDA Label Image

Image 6

FDA Label Image

Image 7

FDA Label Image

Image 8

FDA Label Image

Image 9

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.